Working… Menu

Treatment of Neuropathic Pain in Leprosy (AmyNeLe)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03324035
Recruitment Status : Recruiting
First Posted : October 27, 2017
Last Update Posted : December 28, 2020
Cristália Produtos Químicos Farmacêuticos Ltda.
Information provided by (Responsible Party):
Daniel Ciampi Araujo de Andrade, MD, PhD, University of Sao Paulo

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 2021
Estimated Study Completion Date : March 2021